Effect of Novel AKT Inhibitor Vevorisertib as Single Agent and in Combination with Sorafenib on Hepatocellular Carcinoma in a Cirrhotic Rat Model

Keerthi Kurma; Ayca Zeybek Kuyucu; Gaël Roth; Nathalie Sturm; Marion Mercey-Ressejac; Giovanni Abbadessa; Yi Yu; Herve Lerat; Patrice Marche; Thomas Decaens; Zuzana Macek Jilkova (2022). Effect of Novel AKT Inhibitor Vevorisertib as Single Agent and in Combination with Sorafenib on Hepatocellular Carcinoma in a Cirrhotic Rat Model. International Journal of Molecular Sciences, 23(24), 16206. https://doi.org/10.3390/ijms232416206